We are live on ! Find out more
PIM

Partner Investment Management Portfolio holdings

AUM $13.9M
1-Year Est. Return 55.92%
This Fund
S&P 500
This Quarter Est. Return
+15.92%
1 Year Est. Return
+55.92%
3 Year Est. Return
+168.07%
5 Year Est. Return
+301.91%
10 Year Est. Return
–
AUM
$67.5M
AUM Growth
+$6.33M
Cap. Flow
+$5.94M
Cap. Flow %
8.8%
Top 10 Hldgs %
31.63%
Holding
112
New
35
Increased
20
Reduced
22
Closed
29

Top Buys

Rank Stock Value
1
VYGR icon
Voyager Therapeutics
VYGR
+$1.84M
2
UNP icon
Union Pacific
UNP
+$1.69M
3
JAZZ icon
Jazz Pharmaceuticals
JAZZ
+$1.51M
4
AAPL icon
Apple
AAPL
+$1.4M
5
BIIB icon
Biogen
BIIB
+$1.39M

Top Sells

Rank Stock Value
1
AET
Aetna Inc
AET
+$2.28M
2
AMAT icon
Applied Materials
AMAT
+$1.53M
3
ABBV icon
AbbVie
ABBV
+$1.13M
4
MCK icon
McKesson
MCK
+$1.11M
5
ALDR
Alder Biopharmaceuticals
ALDR
+$1.01M

Sector Composition

Rank Sector Weight
1 Healthcare 48.82%
2 Miscellaneous 11.48%
3 Technology 10.99%
4 Communication Services 8.2%
5 Consumer Discretionary 6.39%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BIIB icon
1
Biogen
BIIB
$32.3B
$3.7M 5.49%
11,828
+4,689
+66% +$1.39M
JAZZ icon
2
Jazz Pharmaceuticals
JAZZ
$15.9B
$2.6M 3.85%
21,391
+11,182
+110% +$1.51M
EW icon
3
Edwards Lifesciences
EW
$52B
$2.37M 3.52%
59,079
-8,970
-13% -$338K
WBA
4
DELISTED
Walgreens Boots Alliance
WBA
$2.01M 2.98%
24,899
+7,174
+40% +$585K
META icon
5
Meta Platforms (Facebook)
META
$1.47T
$2.01M 2.97%
15,640
+2,045
+15% +$254K
VYGR icon
6
Voyager Therapeutics
VYGR
$218M
$1.95M 2.89%
162,278
+136,091
+520% +$1.84M
UNP icon
7
Union Pacific
UNP
$183B
$1.76M 2.6%
+18,018
New +$1.69M
AAPL icon
8
Apple
AAPL
$4.67T
$1.74M 2.58%
61,560
+52,732
+597% +$1.4M
AERI
9
DELISTED
Aerie Pharmaceuticals
AERI
$1.6M 2.37%
42,438
-1,907
-4% -$42.1K
BAX icon
10
Baxter International
BAX
$13.5B
$1.6M 2.37%
33,609
+5,805
+21% +$274K
DISH
11
DELISTED
DISH Network Corp.
DISH
$1.49M 2.21%
27,158
+6,912
+34% +$358K
BMRN icon
12
BioMarin Pharmaceuticals
BMRN
$12.5B
$1.45M 2.15%
15,635
+3,883
+33% +$366K
PANW icon
13
Palo Alto Networks
PANW
$303B
$1.41M 2.08%
52,902
+20,340
+62% +$464K
ALDR
14
DELISTED
Alder Biopharmaceuticals
ALDR
$1.38M 2.04%
41,960
-33,042
-44% -$1.01M
MDCO
15
DELISTED
Medicines Co
MDCO
$1.37M 2.03%
36,352
-14,456
-28% -$545K
NOW icon
16
ServiceNow
NOW
$150B
$1.19M 1.76%
+74,985
New +$1.11M
V icon
17
Visa
V
$712B
$1.15M 1.7%
13,901
+9,919
+249% +$794K
PXD
18
DELISTED
Pioneer Natural Resource Co.
PXD
$1.14M 1.69%
+6,132
New +$1.04M
LLY icon
19
CALL
Eli Lilly
LLY
$1.05T
$1.11M 1.64%
+13,800
New +$1.1M
BMY icon
20
PUT
Bristol-Myers Squibb
BMY
$136B
$1.08M 1.61%
+20,100
New +$1.29M
HUM icon
21
Humana
HUM
$46.3B
$1.04M 1.54%
+5,886
New +$1.02M
BKD icon
22
Brookdale Senior Living
BKD
$2.8B
$1.01M 1.5%
58,009
-9,752
-14% -$168K
HRTX icon
23
Heron Therapeutics
HRTX
$62M
$969K 1.44%
56,258
+7,979
+17% +$148K
RRC icon
24
Range Resources
RRC
$9.69B
$960K 1.42%
+24,771
New +$1M
CME icon
25
CME Group
CME
$103B
$945K 1.4%
+9,042
New +$944K
1
2 3 4 5

Similar funds

SWM
Sequoia Wealth Management Hoffman Estates, Illinois $12.9M AUM 25.75% 1-Year Est. Return
ACM
ADI Capital Management New York $17.5M AUM 49.32% 1-Year Est. Return
ECAU
Everett Capital Advisors (UK) London, United Kingdom $18.6M AUM 22.81% 1-Year Est. Return
SL
Signition LP New York $20M AUM 28.26% 1-Year Est. Return
DII
Domini Impact Investments New York $7.59M AUM 47.68% 1-Year Est. Return
FIM
FourPoints Investment Managers Paris, France $21.1M AUM 11.11% 1-Year Est. Return
EM
Emancipation Management New York $22.4M AUM 18.33% 1-Year Est. Return
BHC
Balch Hill Capital San Francisco, California $22.8M AUM

Partner Investment Management's Q3 2016 Portfolio in Review

As of Q3 2016, Partner Investment Management held 112 positions worth $67.5M, up 10% from $61.1M the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Partner Investment Management deployed $5.94M of net new capital in Q3 2016, opening 35 new positions and adding to 20 existing holdings. Its largest new stake was Union Pacific: 18,018 shares worth $1.76M.

By sector, the portfolio is most concentrated in Healthcare at 49% of assets, up from 46% a quarter earlier, followed by Miscellaneous and Technology.

On the sell side, the largest reduction was AbbVie, an estimated $1.13M trimmed.

  • Partner Investment Management's largest Q3 2016 buy was Union Pacific: 18,018 shares worth $1.76M.
  • Partner Investment Management added most to Voyager Therapeutics in Q3 2016, an estimated $1.84M increase.
  • Partner Investment Management's biggest Q3 2016 reduction was AbbVie, cutting an estimated $1.13M.
  • Partner Investment Management fully exited Aetna Inc in Q3 2016, selling an estimated $2.28M.
  • Partner Investment Management's ten largest holdings make up 32% of its $67.5M portfolio in Q3 2016.
  • Partner Investment Management opened 35 new positions and closed 29 in Q3 2016.
  • Partner Investment Management's portfolio value rose 10% quarter-over-quarter to $67.5M.

Based on Partner Investment Management's 13F filing for Q3 2016, filed 14 Nov 2016.